In this section you will find news on the latest developments within ZoBio.

Read the ZoBio newsletter Last Updated on Thursday, 11 April 2013 07:48 Read more...   ZoBio co-founder Dr. Siegal is co-author of a new NMR method to elucidate the 3D structure of small molecules weakly bound to a protein. Last Updated on Wednesday, 17 April 2013 15:00 Read more...   ZoBio executes exclusive consultancy with Prof. Philip Selenko of the FMP in Berlin Last Updated on Thursday, 21 February 2013 17:37 Read more...   Cell Centric and ZoBio enter into partnership to develop lead compounds against epigenetic drug targets Last Updated on Thursday, 24 January 2013 17:54 Read more...   ZoBio and Heptares Therapeutics announce collaboration Last Updated on Thursday, 24 January 2013 18:00 Read more...

More Articles... ZoBio and Quantum Tessera Partnership ZoBio is pleased to announce an agreement to provide FBDD services to Abbott ZoBio is pleased to announce two new extensions to ongoing colloborations. Collabration with Professor Brian Shoichet Fragment based screening at CRELUX and ZoBio Cancer Research Technology, the ICR and ZoBio Sign Deal to Develop Cancer Drugs NewLink Genetics selects Pyxis Discovery and ZoBio for fragment based drug discovery ZoBio at Fragment-based Lead Discovery Conference 2008, San Diego, CA ZoBio in Dutch Biotech delegation to BioBusinessAsia 2007 UCB selects ZoBio for Fragment Based Drug Discovery services ZoBio participates in new STW funded kinase inhibitor project John van Duynhoven appointed as Scientific Advisory Board member ZoBio technology nominated for most innovative Dutch Idea prize 2006 ZoBio, Bruker BioSpin and Leiden University Announce Successful Completion of a Prototype Dual Cell, Flow Probe ZoBio BV, Galapagos NV, Pyxis Discovery BV and Leiden University collaborate in arthritis drug discovery program